Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 5
1979 4
1980 15
1981 8
1982 31
1983 33
1984 48
1985 73
1986 89
1987 86
1988 126
1989 161
1990 140
1991 174
1992 169
1993 177
1994 158
1995 170
1996 149
1997 140
1998 110
1999 128
2000 141
2001 134
2002 150
2003 163
2004 179
2005 176
2006 163
2007 145
2008 137
2009 131
2010 88
2011 100
2012 115
2013 106
2014 121
2015 102
2016 117
2017 83
2018 89
2019 70
2020 82
2021 87
2022 87
2023 81
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

797 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Interleukin-2-based therapies in cancer.
Raeber ME, Sahin D, Boyman O. Raeber ME, et al. Sci Transl Med. 2022 Nov 9;14(670):eabo5409. doi: 10.1126/scitranslmed.abo5409. Epub 2022 Nov 9. Sci Transl Med. 2022. PMID: 36350987 Review.
Molecular insights into the mechanism of beneficial and adverse effects of interleukin-2 (IL-2) have resulted in the development of improved IL-2 formulations with IL-2 receptor bias and tissue-targeting properties. ...
Molecular insights into the mechanism of beneficial and adverse effects of interleukin-2 (IL-2) have resulted in the developme …
Interleukin-2: Biology, Design and Application.
Arenas-Ramirez N, Woytschak J, Boyman O. Arenas-Ramirez N, et al. Trends Immunol. 2015 Dec;36(12):763-777. doi: 10.1016/j.it.2015.10.003. Epub 2015 Nov 10. Trends Immunol. 2015. PMID: 26572555 Free article. Review.
Interleukin-2 (IL-2) exerts crucial functions during immune homeostasis via its effects on regulatory T (Treg) cells, and the optimizing and fine-tuning of effector lymphocyte responses. ...
Interleukin-2 (IL-2) exerts crucial functions during immune homeostasis via its effects on regulatory T (Treg) cells, and the …
Signaling and Function of Interleukin-2 in T Lymphocytes.
Ross SH, Cantrell DA. Ross SH, et al. Annu Rev Immunol. 2018 Apr 26;36:411-433. doi: 10.1146/annurev-immunol-042617-053352. Annu Rev Immunol. 2018. PMID: 29677473 Free PMC article. Review.
The discovery of interleukin-2 (IL-2) changed the molecular understanding of how the immune system is controlled. ...
The discovery of interleukin-2 (IL-2) changed the molecular understanding of how the immune system is controlled. ...
The Interrelation between Interleukin-2 and Schizophrenia.
Huang Y, Zhang X, Zhou N. Huang Y, et al. Brain Sci. 2022 Aug 30;12(9):1154. doi: 10.3390/brainsci12091154. Brain Sci. 2022. PMID: 36138890 Free PMC article. Review.
Interleukin-2 (IL-2) is a growth factor that regulates T-cell autocrine secretion and has long been considered to be closely related to immune response. ...
Interleukin-2 (IL-2) is a growth factor that regulates T-cell autocrine secretion and has long been considered to be closely r …
Interleukin-2 therapy of cancer-clinical perspectives.
Majidpoor J, Mortezaee K. Majidpoor J, et al. Int Immunopharmacol. 2021 Sep;98:107836. doi: 10.1016/j.intimp.2021.107836. Epub 2021 Jul 1. Int Immunopharmacol. 2021. PMID: 34218217 Review.
Therapeutic potential of interleukin-2 in autoimmune diseases.
Yuan Y, Kolios AGA, Liu Y, Zhang B, Li H, Tsokos GC, Zhang X. Yuan Y, et al. Trends Mol Med. 2022 Jul;28(7):596-612. doi: 10.1016/j.molmed.2022.04.010. Epub 2022 May 24. Trends Mol Med. 2022. PMID: 35624009 Review.
Therefore, restoration of the immune balance represents a promising therapeutic target in autoimmune diseases. Interleukin-2 (IL-2) can promote the expansion and differentiation of different immune cell subsets dose-dependently. ...
Therefore, restoration of the immune balance represents a promising therapeutic target in autoimmune diseases. Interleukin-2 ( …
Interleukin-2 as immunotherapeutic in the autoimmune diseases.
Orozco Valencia A, Camargo Knirsch M, Suavinho Ferro E, Antonio Stephano M. Orozco Valencia A, et al. Int Immunopharmacol. 2020 Apr;81:106296. doi: 10.1016/j.intimp.2020.106296. Epub 2020 Feb 12. Int Immunopharmacol. 2020. PMID: 32058934 Review.
Among its functions are the activation and suppression of immune system responses, induction of cell division and regulation of memory cells. Interleukin 2 (IL-2) is a secretory monomeric glycoprotein composed of 149 amino acids containing a signal peptide of 20 ami …
Among its functions are the activation and suppression of immune system responses, induction of cell division and regulation of memory cells …
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy.
Wang H, Borlongan M, Hemminki A, Basnet S, Sah N, Kaufman HL, Rabkin SD, Saha D. Wang H, et al. Hum Gene Ther. 2023 Sep;34(17-18):878-895. doi: 10.1089/hum.2023.099. Hum Gene Ther. 2023. PMID: 37578106 Review.
Interleukin 2 (IL-2) plays a crucial role in T cell growth and survival, enhancing the cytotoxic activity of natural killer and cytotoxic T cells and thus functioning as a versatile master proinflammatory anticancer cytokine. ...
Interleukin 2 (IL-2) plays a crucial role in T cell growth and survival, enhancing the cytotoxic activity of natural killer an …
797 results